CVS appoints JPMorgan data executive Teresa Heitsenrether to its board
CVS Health has appointed Teresa Heitsenrether, chief data and analytics officer at JPMorgan Chase, to its board of directors. The move comes as the healthcare giant continues investing heavily in technology and artificial intelligence (AI). Effective November 18, Heitsenrether will bring decades of financial services experience and expertise in AI strategy to support CVS' transformation into a consumer-focused health tech company. CVS has been rolling out several AI-powered tools recently, including an engagement platform with an AI assistant for patients and an AI-enabled claims manager. The company plans to invest over $20 billion in technology through 2036 as part of its broader digital strategy. This follows a period of operational improvements at CVS since 2024, which included leadership changes, store closures, cost reductions, and better performance from its insurance division. The board also announced the departure of Larry Robbins, who joined in 2024 after activist hedge fund Glenview Capital Management pushed for reforms. His tenure coincided with a turnaround at CVS that led to record profits and stock price recovery.
Topics: AI strategy CVS data analytics JPMorgan Chase